NCT00003454 - Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 18, 1996

Primary Completion Date

December 28, 2002

Study Completion Date

December 28, 2002

Conditions

Stage IV Breast Cancer

Interventions

DRUG

Antineoplaston therapy (Atengenal + Astugenal)

"Patients with Stage IV Breast Cancer will receive Antineoplaston therapy (Atengenal + Astugenal).~The daily doses of A10 and AS2-1 are divided into six infusions, which are given at 4-hourly intervals. Each infusion starts with infusion of A10 and is immediately followed by infusion of AS2-1."

Trial Locations (1)

77055-6330

Burzynski Clinic, Houston